Zura Bio Limited (ZURA)

Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $574.03 million. The enterprise value is $468.42 million.

Market Cap	574.03M
Enterprise Value	468.42M

Important Dates

The last earnings date was Thursday, March 19, 2026, before market open.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 94.88 million shares outstanding. The number of shares has increased by 25.43% in one year.

Current Share Class	94.88M
Shares Outstanding	94.88M
Shares Change (YoY)	+25.43%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	4.73%
Owned by Institutions (%)	36.71%
Float	52.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.08
P/TBV Ratio	5.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.05

Current Ratio	9.05
Quick Ratio	8.82
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.49% and return on invested capital (ROIC) is -35.96%.

Return on Equity (ROE)	-52.49%
Return on Assets (ROA)	-32.05%
Return on Invested Capital (ROIC)	-35.96%
Return on Capital Employed (ROCE)	-74.11%
Weighted Average Cost of Capital (WACC)	5.24%
Revenue Per Employee	n/a
Profits Per Employee	-$3.31M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +301.34% in the last 52 weeks. The beta is 0.18, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+301.34%
50-Day Moving Average	6.19
200-Day Moving Average	3.68
Relative Strength Index (RSI)	47.16
Average Volume (20 Days)	531,821

Short Selling Information

The latest short interest is 4.74 million, so 4.99% of the outstanding shares have been sold short.

Short Interest	4.74M
Short Previous Month	4.08M
Short % of Shares Out	4.99%
Short % of Float	8.98%
Short Ratio (days to cover)	9.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-75.25M
Pretax Income	-68.65M
Net Income	-99.35M
EBITDA	-75.20M
EBIT	-75.25M
Earnings Per Share (EPS)	-$1.06

Balance Sheet

The company has $109.41 million in cash and n/a in debt, with a net cash position of $109.41 million or $1.15 per share.

Cash & Cash Equivalents	109.41M
Total Debt	n/a
Net Cash	109.41M
Net Cash Per Share	$1.15
Equity (Book Value)	101.54M
Book Value Per Share	1.38
Working Capital	99.90M

Cash Flow

In the last 12 months, operating cash flow was -$64.82 million and capital expenditures -$113,000, giving a free cash flow of -$64.93 million.

Operating Cash Flow	-64.82M
Capital Expenditures	-113,000
Depreciation & Amortization	49,000
Net Borrowing	n/a
Free Cash Flow	-64.93M
FCF Per Share	-$0.68

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.43%
Shareholder Yield	-25.43%
Earnings Yield	-17.19%
FCF Yield	-11.24%

Analyst Forecast

The average price target for Zura Bio is $11.78, which is 94.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.78
Price Target Difference	94.71%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	6.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1